In a recent study using a mouse model of intestinal cancer with gain-of-function mutations in Tpr53, Kadosh et al. observed that mutated p53 functioned as a tumor suppressor in the proximal part of the gut (duodenum and jejunum) by disrupting the Wnt pathway, causing a decrease in cell proliferation [90]. The gene discussed is TP53; the disease is neoplasm.